Scotland, United Kingdom

Arpad Janos Pusztai

This inventor holds 1 USPTO granted patent. Top assignee: Alizyme Therapeutics Limited. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arpad Janos Pusztai. Retrieved from https://idiyas.com/inventor/arpad-janos-pusztai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arpad Janos Pusztai: Innovator in Lectin Research

Introduction

Arpad Janos Pusztai is a notable inventor based in Scotland, GB. He has made significant contributions to the field of biochemistry, particularly in the area of lectin research. His work focuses on the therapeutic applications of lectins, which are proteins that can bind carbohydrates and have various biological functions.

Latest Patents

Pusztai holds a patent for "Lectin compositions and uses thereof." This invention provides methods for controlling mucosal cell proliferation, reducing damage caused by cell-damaging agents, and treating metabolic disorders. The methods involve administering an effective amount of a lectin to individuals in need. This invention takes advantage of the protective and repair capabilities of lectins, making it particularly useful for preventing and treating animals undergoing radiotherapy and/or chemotherapy for cancer. He has 1 patent to his name.

Career Highlights

Pusztai has had a distinguished career, working with Alizyme Therapeutics Limited, where he has been involved in groundbreaking research. His innovative approaches have contributed to advancements in medical treatments and therapies.

Collaborations

Throughout his career, Pusztai has collaborated with esteemed colleagues, including Zsuzsanna Magdolna Bardocz and Richard Michael Palmer. These collaborations have further enriched his research and expanded the impact of his work.

Conclusion

Arpad Janos Pusztai's contributions to lectin research have opened new avenues for medical treatments, particularly in oncology. His innovative patent and collaborative efforts highlight his commitment to advancing scientific knowledge and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…